-
Je něco špatně v tomto záznamu ?
Elevated inflammation markers in pheochromocytoma compared to other forms of hypertension
T Zelinka, O Petrak, B Strauch, R Holaj, J Kvasnicka, J Mazoch, K Pacak, J Jr Widimsky
Jazyk angličtina Země Švýcarsko
NLK
Karger Journals
od 1994 do 2009
- MeSH
- alfa-1-antitrypsin krev MeSH
- alfa-makroglobuliny analýza MeSH
- biologické markery krev MeSH
- C-reaktivní protein analýza MeSH
- dospělí MeSH
- feochromocytom komplikace krev patofyziologie MeSH
- fibrinogen analýza MeSH
- financování organizované MeSH
- hyperaldosteronismus komplikace krev patofyziologie MeSH
- hypertenze etiologie krev MeSH
- lidé středního věku MeSH
- lidé MeSH
- nádory nadledvin komplikace krev patofyziologie MeSH
- neutrofily MeSH
- orosomukoid analýza MeSH
- počet leukocytů MeSH
- počet trombocytů MeSH
- prealbumin analýza MeSH
- transferin analýza MeSH
- zánět komplikace krev MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
OBJECTIVE: To investigate the effect of long-term catecholamine excess in pheochromocytoma on leukocyte and platelet count and on proteins of acute-phase response. METHODS: Fifteen subjects with pheochromocytoma, 16 with primary aldosteronism, 18 with essential hypertension and 17 healthy controls were studied. Sixteen subjects with pheochromocytoma were investigated after tumor removal. Leukocyte, neutrophil and platelet count, as well as C-reactive protein were measured in all subjects, while fibrinogen, alpha(1)-antitrypsin, alpha(2)-macroglobulin, orosomucoid, transferrin and prealbumin were only measured in subjects with pheochromocytoma, primary aldosteronism and essential hypertension. RESULTS: Subjects with pheochromocytoma showed significantly higher leukocyte [7.5 +/- 0.9 10(9)/l, p < 0.001 vs. primary aldosteronism (5.4 +/- 0.9 10(9)/l) and healthy controls (5 +/- 0.9 10(9)/l), p = 0.04 vs. essential hypertension (6.3 +/- 1.6 10(9)/l)], neutrophil (p < 0.001 vs. primary aldosteronism and healthy subjects) and platelet counts (p < 0.001 vs. primary aldosteronism; p = 0.01 vs. essential hypertension) compared to the other groups of subjects. Similar results were obtained for positive proteins of acute-phase response in subjects with pheochromocytoma [C-reactive protein: 0.62 +/- 0.52 mg/dl, p < 0.001 vs. healthy subjects (0.08 +/- 0.08 mg/dl), p = 0.001 vs. primary aldosteronism (0.17 +/- 0.19 mg/dl), p = 0.04 vs. essential hypertension (0.31 +/- 0.26 mg/dl); fibrinogen: p = 0.02 vs. primary aldosteronism; orosomucoid: p = 0.005 vs. primary aldosteronism; alpha(2)-macroglobulin: p = 0.009 vs. primary aldosteronism]. No significant differences were found in plasma levels of alpha(1)-antitrypsin, transferrin and prealbumin. Tumor removal led to a significant decrease in leukocyte (p = 0.004), neutrophil (p = 0.007) and platelet count (p = 0.003) and also to a significant decrease in acute-phase proteins (C-reactive protein: p = 0.03, fibrinogen: p = 0.008, alpha(1)-antitrypsin: p = 0.003, orosomucoid: p = 0.04). CONCLUSIONS: Chronic catecholamine excess in pheochromocytoma is accompanied by an increase in inflammation markers which was reversed by the tumor removal. Copyright 2007 S. Karger AG, Basel.
- 000
- 04583naa 2200637 a 4500
- 001
- bmc10013190
- 003
- CZ-PrNML
- 005
- 20121130125315.0
- 008
- 100602s2007 sz e eng||
- 009
- AR
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Zelinka, Tomáš $7 xx0074465
- 245 10
- $a Elevated inflammation markers in pheochromocytoma compared to other forms of hypertension / $c T Zelinka, O Petrak, B Strauch, R Holaj, J Kvasnicka, J Mazoch, K Pacak, J Jr Widimsky
- 314 __
- $a 3rd Department of Medicine, General Faculty Hospital, Praha, Czech Republic. tzeli@lf1.cuni.cz
- 520 9_
- $a OBJECTIVE: To investigate the effect of long-term catecholamine excess in pheochromocytoma on leukocyte and platelet count and on proteins of acute-phase response. METHODS: Fifteen subjects with pheochromocytoma, 16 with primary aldosteronism, 18 with essential hypertension and 17 healthy controls were studied. Sixteen subjects with pheochromocytoma were investigated after tumor removal. Leukocyte, neutrophil and platelet count, as well as C-reactive protein were measured in all subjects, while fibrinogen, alpha(1)-antitrypsin, alpha(2)-macroglobulin, orosomucoid, transferrin and prealbumin were only measured in subjects with pheochromocytoma, primary aldosteronism and essential hypertension. RESULTS: Subjects with pheochromocytoma showed significantly higher leukocyte [7.5 +/- 0.9 10(9)/l, p < 0.001 vs. primary aldosteronism (5.4 +/- 0.9 10(9)/l) and healthy controls (5 +/- 0.9 10(9)/l), p = 0.04 vs. essential hypertension (6.3 +/- 1.6 10(9)/l)], neutrophil (p < 0.001 vs. primary aldosteronism and healthy subjects) and platelet counts (p < 0.001 vs. primary aldosteronism; p = 0.01 vs. essential hypertension) compared to the other groups of subjects. Similar results were obtained for positive proteins of acute-phase response in subjects with pheochromocytoma [C-reactive protein: 0.62 +/- 0.52 mg/dl, p < 0.001 vs. healthy subjects (0.08 +/- 0.08 mg/dl), p = 0.001 vs. primary aldosteronism (0.17 +/- 0.19 mg/dl), p = 0.04 vs. essential hypertension (0.31 +/- 0.26 mg/dl); fibrinogen: p = 0.02 vs. primary aldosteronism; orosomucoid: p = 0.005 vs. primary aldosteronism; alpha(2)-macroglobulin: p = 0.009 vs. primary aldosteronism]. No significant differences were found in plasma levels of alpha(1)-antitrypsin, transferrin and prealbumin. Tumor removal led to a significant decrease in leukocyte (p = 0.004), neutrophil (p = 0.007) and platelet count (p = 0.003) and also to a significant decrease in acute-phase proteins (C-reactive protein: p = 0.03, fibrinogen: p = 0.008, alpha(1)-antitrypsin: p = 0.003, orosomucoid: p = 0.04). CONCLUSIONS: Chronic catecholamine excess in pheochromocytoma is accompanied by an increase in inflammation markers which was reversed by the tumor removal. Copyright 2007 S. Karger AG, Basel.
- 650 _2
- $a nádory nadledvin $x komplikace $x krev $x patofyziologie $7 D000310
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a biologické markery $x krev $7 D015415
- 650 _2
- $a C-reaktivní protein $x analýza $7 D002097
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a fibrinogen $x analýza $7 D005340
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a hyperaldosteronismus $x komplikace $x krev $x patofyziologie $7 D006929
- 650 _2
- $a hypertenze $x etiologie $x krev $7 D006973
- 650 _2
- $a zánět $x komplikace $x krev $7 D007249
- 650 _2
- $a počet leukocytů $7 D007958
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a neutrofily $7 D009504
- 650 _2
- $a orosomukoid $x analýza $7 D009961
- 650 _2
- $a feochromocytom $x komplikace $x krev $x patofyziologie $7 D010673
- 650 _2
- $a počet trombocytů $7 D010976
- 650 _2
- $a prealbumin $x analýza $7 D011228
- 650 _2
- $a transferin $x analýza $7 D014168
- 650 _2
- $a alfa-1-antitrypsin $x krev $7 D000515
- 650 _2
- $a alfa-makroglobuliny $x analýza $7 D000511
- 650 _2
- $a financování organizované $7 D005381
- 700 1_
- $a Petrák, Ondřej $7 xx0104500
- 700 1_
- $a Štrauch, Branislav. $7 xx0035015
- 700 1_
- $a Holaj, Robert $7 xx0074140
- 700 1_
- $a Kvasnička, Jan, $d 1943- $7 mzk2003187694
- 700 1_
- $a Mazoch, Jiří. $7 _BN003617
- 700 1_
- $a Pacák, Karel, $d 1958- $7 jo20000074102
- 700 1_
- $a Widimský, Jiří, $d 1956- $7 jn99240001422
- 773 0_
- $t Neuroimmunomodulation $w MED00003488 $g Roč. 14, č. 1 (2007), s. 57-64 $x 1021-7401
- 910 __
- $a ABA008 $b x $y 7
- 990 __
- $a 20110413110753 $b ABA008
- 991 __
- $a 20121130125344 $b ABA008
- 999 __
- $a ok $b bmc $g 749080 $s 612685
- BAS __
- $a 3
- BMC __
- $a 2007 $b 14 $c 1 $d 57-64 $i 1021-7401 $m Neuroimmunomodulation $n Neuroimmunomodulation $x MED00003488
- LZP __
- $a 2010-B2/ipme